We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Myriad diversifies, fights rearguard action on patents.
- Authors
Allison, Malorye
- Abstract
The article focuses on the lawsuit filled by the genetic laboratory Myriad against diagnostic firm Gene-by-Gene on July 2013 for infringement of nine patents of Myriad related to breast cancer 1 early onset gene BRCA1 and BRCA2. It also mentions the patent infringement suits filed by Myriad against several healthcare industries including Madison, Aliso Viejo and LabCorp. Also mentions the investment of Myriad in detection of cancer mutations.
- Subjects
ACTIONS &; defenses (Law); MYRIAD Genetics Inc.; GENE by Gene Ltd.; PATENT infringement; BREAST cancer; LAB Corp.
- Publication
Nature Biotechnology, 2014, Vol 32, Issue 3, p211
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0314-211a